# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 3A


Where the application relates to the inactivation of viral or non-conventional agents, a statement of the manufacturing process to which the authorisation is to relate.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/6/paragraph/3A (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-6/paragraph-3A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.